Pulmonary Fibrosis Treated with Inhaled Interferon-gamma (IFN-γ)

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 28, Issue 5, 2015, Pages 406-410

  Fusiak, Timothy ^a   Smaldone, Gerald C ^a   Condos, Rany ^b  

^a STONY BROOK UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

aerosols; interstitial lung disease; nebulizers; pulmonary function test

Indexed keywords

ANTINUCLEAR ANTIBODY; C REACTIVE PROTEIN; GAMMA1B INTERFERON; LEVOTHYROXINE; METOPROLOL; OMEPRAZOLE; RHEUMATOID FACTOR; SCL 70 ANTIBODY; SILDENAFIL; GAMMA INTERFERON;

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG TOLERABILITY; ERYTHROCYTE SEDIMENTATION RATE; EXERCISE TOLERANCE; FIBROSING ALVEOLITIS; HUMAN; INTERSTITIAL PNEUMONIA; LONG TERM CARE; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; MALE; MIDDLE AGED; OPEN LUNG BIOPSY; TOTAL LUNG CAPACITY; TREATMENT DURATION; IDIOPATHIC PULMONARY FIBROSIS; INHALATIONAL DRUG ADMINISTRATION; LUNG; PATHOPHYSIOLOGY;

ADMINISTRATION, INHALATION; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; INTERFERON-GAMMA; LUNG; MALE; MIDDLE AGED;

EID: 84943252027     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2015.1221     Document Type: Article

References (11)

1. King TE Jr., Albera C, Bradford WZ, Costabel U, Hormel P, Lancaster L, Noble PW, Sahn SA, Szwarcberg J, Thomeer M, Valeyre D, and du Bois RM: Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): A multicentre, randomised, placebo-controlled trial. Lancet. 2009;374:222-228.
2. Raghu G, Brown KK, Bradford WZ, Starko K, Noble PW, Schwartz DA, and King TE, Jr: A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2004;350: 125-133.
3. Dawson R, Condos R, Tse D, Huie ML, Ress S, Tseng CH, Brauns C, Weiden M, Hoshino Y, Bateman E, and Rom WN: Immunomodulation with recombinant interferongamma1b in pulmonary tuberculosis. PLoS One. 2009;4: e6984.
4. Diaz KT, Skaria S, Harris K, Solomita M, Lau S, Bauer K, Smaldone GC, and Condos R: Delivery and safety of inhaled interferon-gamma in idiopathic pulmonary fibrosis. J Aerosol Med Pulm Drug Deliv. 2012;25:79-87.
5. Strieter RM, Starko KM, Enelow RI, Noth I, Valentine VG, and Idiopathic Pulmonary Fibrosis Biomarkers Study G: Effects of interferon-gamma 1b on biomarker expression in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2004;170:133-140.
6. Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, Kim DS, Kolb M, Nicholson AG, Noble PW, Selman M, Taniguchi H, Brun M, Le Maulf F, Girard M, Stowasser S, Schlenker-Herceg R, Disse B, Collard HR, and Investigators IT: Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014;370:2071-2082.
7. King TE, Jr., Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, Lederer DJ, Nathan SD, Pereira CA, Sahn SA, Sussman R, Swigris JJ, Noble PW, and Group AS: A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014;370: 2083-2092.
8. Iyer SN, Gurujeyalakshmi G, and Giri SN: Effects of pirfenidone on transforming growth factor-beta gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis. J Pharmacol Exper Therapeut. 1999; 291:367-373.
9. Chaudhary NI, Roth GJ, Hilberg F, Muller-Quernheim J, Prasse A, Zissel G, Schnapp A, and Park JE: Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis. Eur Respir J. 2007;29:976-985.
10. Jaffe HA, Buhl R, Mastrangeli A, Holroyd KJ, Saltini C, Czerski D, Jaffe HS, Kramer S, Sherwin S, and Crystal RG: Organ specific cytokine therapy. Local activation of mononuclear phagocytes by delivery of an aerosol of recombinant interferon-gamma to the human lung. J Clin Investig. 1991;88:297-302.
11. Raju B, Hoshino Y, Kuwabara K, Belitskaya I, Prabhakar S, Canova A, Gold JA, Condos R, Pine RI, Brown S, Rom WN, and Weiden MD: Aerosolized gamma interferon (IFN-gamma) induces expression of the genes encoding the IFN-gamma-inducible 10-kilodalton protein but not inducible nitric oxide synthase in the lung during tuberculosis. Infect Immun. 2004;72:1275-1283.